(-)-Galantamine

Specifications

357-70-0CAS Number

609-175-3EC Number

(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-olIUPAC Name

C17H21NO3Chemical Formula

287.35 g/molMolecular Weight

galanthamine; Galantamine; 357-70-0; (-)-Galanthamine; Lycoremine; Galantamina; (-)-Galantamine; Reminyl; Galanthaminum; Galantaminum; NSC-100058; 0D3Q044KCA; DTXSID2045606; (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol; CHEBI:42944; (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol; Reminyl XL; (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol; Galzemic xl; Lotprosin xl; Consion xl; Gatalin xl; Gazylan xl; Luventa xl; Zeebral xl; Acumor xl; Elmino xl; Galsya xl; (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo(8.6.1.01,12.06,17)heptadeca-6(17),7,9,15-tetraen-14-ol; RefChem:56716; DTXCID0025606; N06DA04; 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-; Lycoremin; Jilkon; (+/-)-Galantamine; Bodamine; 23173-12-8; (+/-)-Galanthamine; Reminyl (TN); Galantamine, (+/-)-; MFCD00867189; Galanthamine, (+/-)-; CHEMBL659; 1T835Z585R; (4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol; Galanthamine HBr; Galantaminum [INN-Latin]; GNT; Galantamina [INN-Spanish]; NSC 100058; CHEMBL1555; (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6,8,10(17),15-tetraen-14-ol; 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aR,6S,8aR)-rel-; 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-; 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-; BRN 0093736; HSDB 7361; Galantamine (USAN/INN); UNII-0D3Q044KCA; Galantamine [USAN:INN:BAN]; SR-05000001783; Galanthamine-HBr; 1qti; Galanthamine, 12; (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-ol; Spectrum_001271; 1dx6; Galanthamine (Standard); Galanthamine Impurity 3; GALANTAMINE [MI]; Prestwick0_000588; Prestwick1_000588; Prestwick2_000588; Prestwick3_000588; Spectrum3_001738; Spectrum4_000839; Spectrum5_001673; GALANTAMINE [INN]; GALANTAMINE [HSDB]; GALANTAMINE [USAN]; Galanthamine hydrogenbromide; Probes1_000055; Probes2_000395; GALANTAMINE [VANDF]; SCHEMBL2577; BSPBio_000436; BSPBio_003416; GALANTAMINE [WHO-DD]; KBioGR_001417; KBioSS_001751; 4-27-00-02184 (Beilstein Handbook Reference); BIDD:GT0517; DivK1c_000590; SPBio_002655; BPBio1_000480; GTPL6693; orb1225208; orb1302305; SCHEMBL4696585; SCHEMBL7166507; SCHEMBL29379520; UNII-1T835Z585R; ASUTZQLVASHGKV-JDFRZJQESA-; BDBM10404; KBio1_000590; KBio2_001751; KBio2_004319; KBio2_006887; KBio3_002636; ASUTZQLVASHGKV-JDFRZJQESA-N; NINDS_000590; GLXC-03030; HMS2089H03; HMS3885C10; Pharmakon1600-01501202; MSK10278; BDBM50241745; EBC-26461; HY-76299R; NSC759861; AKOS015965330; CCG-212961; CS-1217; DB00674; FH15703; NSC-759861; SDCCGMLS-0066737.P001; T4S1725; IDI1_000590; SMP1_000131; NCGC00017256-05; NCGC00017256-11; NCGC00017256-17; NCGC00024731-02; AC-20240; AC-34328; AS-56354; HY-76299; SBI-0051689.P002; NS00003061; A11538; C08526; D04292; EN300-708805; AB00053614-09; AB00053614_10; AC-542/20973006; Q412690; Galanthamine ( Jilkon, Lycoremine, Nivalin and oth; SR-05000001783-4; BRD-K49481516-001-01-5; BRD-K49481516-004-03-5; BRD-K49481516-004-04-3; BRD-K49481516-004-09-2; BRD-K49481516-004-18-3; (4aS,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol; 1008759-59-8; 6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4A.ALPHA.,6.BETA.,8AR*)-; 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aalpha,6beta,8ar*)-; 6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4AS,6R,8AS); InChI=1/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1; Rel-(4aR,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol; GalatamineSynonyms